Preparation and Structure-Activity Relationships of Novel Asterriquinone Derivatives

Asterriquinone (ARQ, 1a) is an antitumor metabolite of Aspergillus terreus IFO 6123. To gain insight into the structure-activity relationships of ARQ, a series of chemically modified derivatives (1-6), the ARQ analogues (b-e) and the 2, 5-dihydroxy-p-bezoquinone analogues (f-h), were prepared, and c...

Full description

Saved in:
Bibliographic Details
Published in:Chemical & pharmaceutical bulletin Vol. 46; no. 8; pp. 1325 - 1329
Main Authors: KAJI, Akira, KIMURA, Kengo, TERANISHI, Masanori, KIRIYAMA, Noriki, NOMURA, Masaaki, MIYAMOTO, Ken-ichi
Format: Journal Article
Language:English
Published: Tokyo The Pharmaceutical Society of Japan 1998
Maruzen
Japan Science and Technology Agency
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Asterriquinone (ARQ, 1a) is an antitumor metabolite of Aspergillus terreus IFO 6123. To gain insight into the structure-activity relationships of ARQ, a series of chemically modified derivatives (1-6), the ARQ analogues (b-e) and the 2, 5-dihydroxy-p-bezoquinone analogues (f-h), were prepared, and cytotoxic acitivity against mouse leukemia P388 cells investigated. Results indicated that : 1) at least one hydroxy group or acetoxy group in the p-benzoquinone moiety is important to exhibit cytotoxicity; 2) in the p-benzoquinone moiety, a single methoxy group and/or one aceotxy group substitution showed more potent cytotoxicity than when two hydroxy groups are substituted (1); 3) the indole ring is important for the cytotoxicity of ARQ analogues; 4) the 1, 1-dimethly-2-propenyl group in the indole ring is not important for the cytotoxic activity of ARQ.
AbstractList Asterriquinone (ARQ, 1a) is an antitumor metabolite of Aspergillus terreus IFO 6123. To gain insight into the structure-activity relationships of ARQ, a series of chemically modified derivatives (1-6), the ARQ analogues (b-e) and the 2, 5-dihydroxy-p-bezoquinone analogues (f-h), were prepared, and cytotoxic acitivity against mouse leukemia P388 cells investigated. Results indicated that : 1) at least one hydroxy group or acetoxy group in the p-benzoquinone moiety is important to exhibit cytotoxicity; 2) in the p-benzoquinone moiety, a single methoxy group and/or one aceotxy group substitution showed more potent cytotoxicity than when two hydroxy groups are substituted (1); 3) the indole ring is important for the cytotoxicity of ARQ analogues; 4) the 1, 1-dimethly-2-propenyl group in the indole ring is not important for the cytotoxic activity of ARQ.
Author NOMURA, Masaaki
KAJI, Akira
MIYAMOTO, Ken-ichi
TERANISHI, Masanori
KIRIYAMA, Noriki
KIMURA, Kengo
Author_xml – sequence: 1
  fullname: KAJI, Akira
– sequence: 2
  fullname: KIMURA, Kengo
– sequence: 3
  fullname: TERANISHI, Masanori
– sequence: 4
  fullname: KIRIYAMA, Noriki
– sequence: 5
  fullname: NOMURA, Masaaki
– sequence: 6
  fullname: MIYAMOTO, Ken-ichi
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2406327$$DView record in Pascal Francis
BookMark eNpFkE1P3DAQhq0KJBbaE38gUrmhbMefSY4rPtpKCBDQszVxJsWrNAm2sxL_vkl3RS_jw_v4mdF7yo76oSfGzjmsuVDlNzfWa2XWXAr9ia24VEWuhZBHbAUAVS6kkSfsNMYtgNBQyBV7eQw0YsDkhz7DvsmeU5hcmgLlG5f8zqf37Im6f3l89WPMhja7H3bUZZuYKAT_Nvnliuyagt_N3I7iZ3bcYhfpy-E9Y79ub16ufuR3D99_Xm3ucqeLMuUFGN0g6qoEx0tVYaOgbmSlWq6qWtdF3SAZp9tWc4HGmRKwakpVIFU1kJFn7OveO4bhbaKY7HaYQj-vtFwZkBwKDjN1uadcGGIM1Nox-D8Y3i0Hu9Rm59qsMnapbaYvDk6MDrs2YO98_PgiFBgpihm73mPbmPA3feQYkncdLUpe6XLRHsZi_x-_YrDUy79UZofn
CODEN CPBTAL
CitedBy_id crossref_primary_10_1002_cbic_201300610
crossref_primary_10_1002_chin_199906199
crossref_primary_10_1021_cc070062m
crossref_primary_10_1002_chem_201502287
crossref_primary_10_1002_slct_202202060
crossref_primary_10_1007_s10593_005_0210_8
crossref_primary_10_3390_51201291
crossref_primary_10_1039_B909987P
crossref_primary_10_1016_j_phytochem_2009_06_016
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
1998 INIST-CNRS
Copyright Japan Science and Technology Agency 1998
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: 1998 INIST-CNRS
– notice: Copyright Japan Science and Technology Agency 1998
DBID IQODW
AAYXX
CITATION
7TK
7TM
7U9
H94
DOI 10.1248/cpb.46.1325
DatabaseName Pascal-Francis
CrossRef
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
DatabaseTitleList
AIDS and Cancer Research Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5223
EndPage 1329
ExternalDocumentID 3133304991
10_1248_cpb_46_1325
2406327
article_cpb1958_46_8_46_8_1325_article_char_en
GroupedDBID ---
.55
2WC
53G
5GY
6J9
AAUGY
ABTAH
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
L7B
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZGI
ZY4
.GJ
29B
3O-
AABQG
BKOMP
E3Z
IQODW
JMI
MOJWN
X7J
XSB
ZE2
AAYXX
CITATION
7TK
7TM
7U9
H94
ID FETCH-LOGICAL-c578t-7065daa5980c1849ad40bd394f149b5b7bdae6c5ff512a6c680a9d847ae9b0e63
ISSN 0009-2363
IngestDate Thu Oct 10 16:58:06 EDT 2024
Fri Aug 23 01:31:00 EDT 2024
Sun Oct 29 17:08:51 EDT 2023
Thu Aug 17 20:25:56 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Antineoplastic agent
Nitrogen heterocycle
Quinone
Rodentia
P388-Leukemia
Cytotoxicity
In vitro
Vertebrata
Mammalia
Structure activity relation
Mouse
Animal
Bicyclic compound
Benzenic compound
Aromatic compound
Indole derivatives
Chemical synthesis
Tumor cell
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c578t-7065daa5980c1849ad40bd394f149b5b7bdae6c5ff512a6c680a9d847ae9b0e63
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb1958/46/8/46_8_1325/_article/-char/en
PQID 1460310710
PQPubID 1996362
PageCount 5
ParticipantIDs proquest_journals_1460310710
crossref_primary_10_1248_cpb_46_1325
pascalfrancis_primary_2406327
jstage_primary_article_cpb1958_46_8_46_8_1325_article_char_en
PublicationCentury 1900
PublicationDate 1998-00-00
PublicationDateYYYYMMDD 1998-01-01
PublicationDate_xml – year: 1998
  text: 1998-00-00
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
PublicationTitle Chemical & pharmaceutical bulletin
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationYear 1998
Publisher The Pharmaceutical Society of Japan
Maruzen
Japan Science and Technology Agency
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Maruzen
– name: Japan Science and Technology Agency
References b) Shimizu S., Yamamoto Y., Koshimura S., Chem. Pharm. Bull., 30, 1896-1899 (1982
b) Anslow W.K., Raistrick H., J. Chem. Soc., 1939, 1446-1457
c) Kitanaka S., Takido M., Yakugaku Zasshi, 106, 302-306 (1986).
c) Jones R.G., Shonle H.A., J. Am. Chem. Soc., 67, 1034-1035 (1945
b) Meijer C., Mulder N.H., Timmer-Bosscha H., Zijlatra J.G., De Vries E.G.E., Cancer Res., 47, 4613-4617 (1987).
b) Kaji A., Iwata T., Kiriyama N., Wakusawa S., Miyamoto K., Chem. Pharm. Bull., 42, 1682-1684 (1994
c) Shimizu S., Yamamoto Y., Inagaki J., Koshimura S., Gann, Jpn. J. Cancer Res., 73, 642-648 (1982).
c) Cameron D.W., Giles R.G.F., J. Chem. Soc., 1968, 1461-1464.
10) Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B., Cancer Res., 47, 936-942 (1987).
2) a) Yamamoto Y., Nishimura K., Kiriyama N., Chem. Pharm. Bull., 24, 1853-1859 (1976
8) a) Tsuda Y., Nunozawa T., Nitta K., Yamamoto Y., Chem. Pharm. Bull., 28, 920-925 (1980
13) Arai K., Ph. D. Thesis, Kyoto University, Kyoto, Japan, 1984.
b) Moore R.E., Singh H., Scheuer P.J., J. Org. Chem., 31, 3645-3650 (1966
b) Schill G., Henschel R., Justus Liebigs Ann. Chem., 731, 113-119 (1970
c) Arai K., Shimizu S., Taguchi Y., Yamamoto Y., Chem. Pharm. Bull., 29, 991-999 (1981).
6) a) Fierz-David H.E., Blangey L., Streiff H., Helv. Chim. Acta, 29, 1718-1764 (1946
d) Anslow W.K., Ashley J.N., Raistrick H., J. Chem. Soc., 1938, 439-442.
1) Kaji A., Kimura K., Iwata T., Kiriyama N., Chem. Pharm. Bull., 43, 1818-1820 (1995).
3) a) Yamamoto Y., Kiriyama N., Shimizu S., Koshimura S., Gann, Jpn. J. Cancer Res., 67, 623-624 (1976
5) Kaji A., Iwata T., Kiriyama N., Nomura M., Miyamoto K., J Antibiot., 51, 235-238 (1998).
4) Kaji A., Saito R., Nomura M., Miyamoto K., Kiriyama N., Anticancer Res., 17, 3675-3680 (1997).
9) Besl H., Bresinsky A., Geigenmuller G., Herrmann R., Kilpert C., Steglich W., Justus Liebigs Ann. Chem., 1989, 803-810.
11) a) Calabresi P., Chabner B.A., "Pharmacologic Basis of Therapeutics," ed. by Gilman A.G., Rall T.W., Nies A.S., Taylor P., Pergamon Press, New York, 1990, pp. 1202-1263
7) a) Farfan N., Ortega E., Contreras R., J. Heterocycl. Chem., 23, 1609-1612 (1986
References_xml
SSID ssj0025073
Score 1.5961499
Snippet Asterriquinone (ARQ, 1a) is an antitumor metabolite of Aspergillus terreus IFO 6123. To gain insight into the structure-activity relationships of ARQ, a series...
SourceID proquest
crossref
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1325
SubjectTerms Antineoplastic agents
asterriquinone
Biological and medical sciences
cytotoxicity
General aspects
Medical sciences
mouse leukemia P388 cell
partial deacetylation
Pharmacology. Drug treatments
structure-activity relationship
Title Preparation and Structure-Activity Relationships of Novel Asterriquinone Derivatives
URI https://www.jstage.jst.go.jp/article/cpb1958/46/8/46_8_1325/_article/-char/en
https://www.proquest.com/docview/1460310710
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 1998/08/15, Vol.46(8), pp.1325-1329
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfK4ICEEJ9aYUM-TLuwjCxfdQ4cIpZpZaNUXSqNU2THDguTmtKuk_bf817sfGkIwYFLFCVOo_j3-vN7tt_vEbKXhy5jwI2Wk-XMAqOwLeHYrsWkD0_kR7ao8rhPL0aTS3Yce_FgUNfEa6_9V6ThGmCNmbP_gHbzo3ABzgFzOALqcPwr3KcrpeW8zTbji0ogdrNSVpSZShHNBrirYlnt5JiUtwqRukGZxp-bYlEucDvRqqp8dmt2GdZyBrXCANrM8qo3Iy66Wt7I4tHncUU-18Wqof-z8Zf5LDI5Qd_LZuognkUTnD3TGURrvihXRfvMbPwNFwP0SlNxXbSzFZi-144hMPa3hIXf364dvI-qPNMeT4eW4xrqU5qaXW8EYbPOTq6520xfahtlHSKGINv_7QjheJj1kC3FoRcc1q36OtyTr-nJ_Pw8TeLLpH9Xj_sQ1uPiJGomPHSA37BwxvH4rInzwcVuCvjhR5i0UHjzh857e47Qox8QC6DIw5MlXwNgua6qcs9BqLye5Bl5asIVGmk7e04GavGC7E817HcHNGnT99YHdJ9OWyX0u5ck6RgjBTDofWOkPWOkZU4rY6R9Y6QdY3xF5idx8unUMmU8rAyGgxsLF9Il537I7OyIeSGXni2kG3o5ROfCFyMhuQoyP8_B-eRBFjCbhxK8Jq5CYavAfU228FXbhPKRyIQKQ_DTpcccyXI4l56fo2wc9-WQ7NV9mi61WkuKUS50fQpdn3pBil0_JB91fzeNzN8VG6H6EjY0B2zf3oZOBJIZkt0eTM3PoHvsOqMh2alhSw01rDHGRhle8Ojf_Pn2W_JYJ77iPN8O2QJk1C55sJabd5Wd_QJ5YrRz
link.rule.ids 315,782,786,4028,27932,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preparation+and+Structure-Activity+Relationships+of+Novel+Asterriquinone+Derivatives&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=KAJI%2C+Akira&rft.au=KIMURA%2C+Kengo&rft.au=TERANISHI%2C+Masanori&rft.au=KIRIYAMA%2C+Noriki&rft.date=1998&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=46&rft.issue=8&rft.spage=1325&rft_id=info:doi/10.1248%2Fcpb.46.1325&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3133304991
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon